Bone fragility in patients with alcoholic liver cirrhosis: can hip structure analysis better predict risk of hip fracture

2013 ◽  
Author(s):  
Danijela Djonic ◽  
Djordje Culafic ◽  
Violeta Culafic-Vojinovic ◽  
Svetlana Ignjatovic ◽  
Ivan Soldatovic ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Hip Fracture ◽  
Structure Analysis ◽  
Bone Fragility ◽  
Alcoholic Liver Cirrhosis ◽  
Hip Structure Analysis ◽  
Hip Structure

scholarly journals Hip structure analysis by DXA of teriparatide treatment: A 24-month follow-up clinical study

2016 ◽  
Vol 13 (4) ◽  
pp. 414-418 ◽  
Author(s):  
Takeshi Mochizuki ◽  
Koichiro Yano ◽  
Katsunori Ikari ◽  
Kosei Kawakami ◽  
Ryo Hiroshima ◽  
...  
Keyword(s):  
Clinical Study ◽  
Structure Analysis ◽  
Hip Structure Analysis ◽  
Teriparatide Treatment ◽  
Hip Structure

scholarly journals Ethnic variability in bone geometry as assessed by hip structure analysis: Findings from the hip strength across the menopausal transition study

2013 ◽  
Vol 28 (4) ◽  
pp. 771-779 ◽  
Author(s):  
Michelle E Danielson ◽  
Thomas J Beck ◽  
Yinjuan Lian ◽  
Arun S Karlamangla ◽  
Gail A Greendale ◽  
...  
Keyword(s):  
Structure Analysis ◽  
Bone Geometry ◽  
Menopausal Transition ◽  
Hip Structure Analysis ◽  
Hip Strength ◽  
Ethnic Variability ◽  
Transition Study ◽  
Hip Structure

The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis

Bone ◽  
2015 ◽  
Vol 77 ◽  
pp. 115-119 ◽  
Author(s):  
Thomas J. Beck ◽  
Thomas Fuerst ◽  
Kenneth W. Gaither ◽  
Santosh Sutradhar ◽  
Amy B. Levine ◽  
...  
Keyword(s):  
Structure Analysis ◽  
Structural Strength ◽  
Hip Structure Analysis ◽  
Hip Structure

scholarly journals Sarcopenia negatively affects hip structure analysis variables in a group of Lebanese postmenopausal women

2020 ◽  
Vol 21 (S2) ◽  
Author(s):  
Hayman Saddik ◽  
Riad Nasr ◽  
Antonio Pinti ◽  
Eric Watelain ◽  
Ibrahim Fayad ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Structure Analysis ◽  
Hip Structure Analysis ◽  
Hip Structure

scholarly journals Combined Use of Ibandronate and Eldecalcitol in Postmenopausal Japanese Women with Osteoporosis

2016 ◽  
Vol 24 (3) ◽  
pp. 362-366 ◽  
Author(s):  
Junichi Takada ◽  
Hiroshi Wada ◽  
Kousuke Iba ◽  
Kouichi Sasaki ◽  
Takayuki Dohke ◽  
...  
Keyword(s):  
Lumbar Spine ◽  
Femoral Neck ◽  
Bone Strength ◽  
Structure Analysis ◽  
Proximal Femur ◽  
Japanese Women ◽  
Hip Structure Analysis ◽  
Narrow Neck ◽  
Combined Use ◽  
Hip Structure

Purpose To evaluate the effect of combined use of ibandronate and eldecalcitol for 6 to 12 months on bone mineral density (BMD) and bone strength of the proximal femur in postmenopausal Japanese women with osteoporosis. Methods BMD and bone strength of the proximal femur were evaluated in 78 postmenopausal women (mean age, 73.6 years) who underwent treatment for osteoporosis with combined use of ibandronate and eldecalcitol for at least 6 months. BMD was measured at the lumbar spine, femoral neck, and total hip using dual-energy X-ray absorptiometry (DXA) at baseline and every 6 months thereafter. Hip structure analysis of the narrow neck and intertrochanter was performed by a radiologist using DXA images. Results Respectively for the lumbar spine, femoral neck, and total hip, BMD significantly increased (from baseline) by 4.54%, 2.31%, and 1.56% at 6 months and by 5.92%, 3.02%, and 2.70% at 12 months. In hip structure analysis, most parameters improved significantly. Respectively for the narrow neck and intertrochanter, BMD significantly increased (from baseline) by 2.37% and 2.71% at 6 months and by 3.46% and 3.52% at 12 months; cross-sectional area significantly increased by 1.83% and 3.39% at 6 months and by 2.91% and 3.46% at 12 months; section modulus significantly increased by 2.42% and 4.11% at 6 months and by 4.84% and 3.26% at 12 months; cortical thickness significantly increased by 2.49% and 3.33% at 6 months and by 3.73% and 3.37% at 12 months; and buckling ratio significantly decreased by 2.97% and 2.57% at 6 months and by 3.86% and 2.99% at 12 months. Conclusion Combined use of ibandronate and eldecalcitol for 6 months significantly improved bone strength of the proximal femur in postmenopausal Japanese women with osteoporosis.

Sign in / Sign up

Export Citation Format

Share Document